Benzinga | Nov 5, 2021 09:46AM EDT

Jefferies Maintains Buy on Zimmer Biomet Holdings, Lowers Price Target to $175

Jefferies analyst Anthony Petrone maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and lowers the price target from $200 to $175.